Rachael Louise Brake - 06 Dec 2021 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role
Chief Scientific Officer
Signature
/s/ Rachael Brake
Issuer symbol
CRBP
Transactions as of
06 Dec 2021
Net transactions value
$0
Form type
4
Filing time
08 Dec 2021, 15:04:38 UTC
Next filing
02 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBP Stock Option(right to buy) Award $0 +500,000 $0.000000 500,000 06 Dec 2021 Common Stock 500,000 $0.7474 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on December 6, 2022, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on January 6, 2023.